Senators and ask that they continue to support the inclusion of “scleroderma” as
a condition eligible for study through the Department of Defense Peer-Reviewed
Medical Research Program during the Fiscal Year (FY) 2017 appropriations
are currently working on the FY 2017 DoD appropriations bill and deciding which
conditions will be included on the next PRMRP eligible conditions list. Being
included on the list one year is no guarantee of being included again in the
next year. At this critical time, please reach out to the offices of your
Senators and ask that they “once again support the inclusion of scleroderma in
the DoD PRMRP’s eligible conditions list in FY 2017.”
Scholarship Applications Now Being Accepted for 2016 Conference
The deadline for scholarship applications is coming up. The scholarship program is a tremendous opportunity for first time attendees to attend the National Patient Education Conference. Thanks to the generous support of many donors and chapters,
conference scholarships will be available to the 2016 National Patient
Education Conference in New Orleans, LA, from July 29-31, 2016.
Smoking is the leading cause of preventable disease, disability and death in the United States. According to the Centers for Disease Control and Prevention, smoking cigarettes causes 480,000 premature deaths in the United States EACH year. This convenient Quit Smoking guide will provide you with all the information you need to make that process as easy and effective as possible.
A growing amount of research suggests that having a positive outlook can benefit your physical health. The National Institutes of Health is working to better understand the links between your attitude and your body. They are finding some evidence that emotional wellness can be improved by developing certain skills. Being open to positive change is a key!
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
The Scleroderma Foundation is a qualified national nonprofit operating under 501(c)(3) status. The foundation’s federal tax identification number is 52-1375827. Our primary goal is to raise funds for our three-fold mission of support, education and research. The foundation has 20 active chapters and 160 support groups across the country.